Intech Investment Management LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 8.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,150 shares of the biotechnology company's stock after acquiring an additional 1,080 shares during the quarter. Intech Investment Management LLC's holdings in Axon Enterprise were worth $6,916,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. GAMMA Investing LLC boosted its position in shares of Axon Enterprise by 58,725.5% in the first quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after purchasing an additional 763,431 shares during the period. Jennison Associates LLC lifted its stake in shares of Axon Enterprise by 23,203.7% during the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after buying an additional 611,418 shares in the last quarter. Nuveen LLC bought a new position in Axon Enterprise in the 1st quarter worth $264,796,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after buying an additional 212,931 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock valued at $4,540,005,000 after acquiring an additional 185,571 shares during the period. Institutional investors own 79.08% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Bank of America upped their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Wolfe Research started coverage on Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Raymond James Financial restated an "outperform" rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. UBS Group reiterated a "neutral" rating and set a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Needham & Company LLC set a $870.00 target price on shares of Axon Enterprise and gave the stock a "buy" rating in a report on Tuesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus target price of $837.69.
Check Out Our Latest Stock Report on Axon Enterprise
Insiders Place Their Bets
In other news, President Joshua Isner sold 15,919 shares of the business's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Jennifer H. Mak sold 75 shares of the company's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $723.50, for a total transaction of $54,262.50. Following the sale, the chief accounting officer owned 15,080 shares in the company, valued at $10,910,380. This represents a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 44,790 shares of company stock worth $34,304,947. Insiders own 5.70% of the company's stock.
Axon Enterprise Price Performance
NASDAQ AXON traded up $5.02 during trading on Friday, hitting $756.13. 303,694 shares of the stock traded hands, compared to its average volume of 447,052. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12-month low of $375.71 and a 12-month high of $885.91. The firm has a 50-day simple moving average of $761.10 and a 200-day simple moving average of $688.38. The company has a market capitalization of $59.36 billion, a P/E ratio of 186.70, a price-to-earnings-growth ratio of 27.75 and a beta of 1.40.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the company earned $1.20 EPS. The company's quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
